I/ONTAK'spotentialmarket is>$300mInsidersinvested$26.5mI'm ashareholdermyselfOur Halo-Lido trial willhave finalpatient byend of 2022An actualiMSCupdateWe haveenough cashto go wellinto 2023We expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketI/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022Only biotechwith 2 Myron'son theleadershipteamMyron Holubiakand I founded aprivatecompany in2013We had aphase 2btrial with100%efficacyMino-WrapI won't diluteshareholdersMino-Lokis our leadassetWe will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"There are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityI/ONTAKis our leadassetI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokpotentialmarket>$1BNot manycompaniesthis size with2 late stageassetsI/ONTAK'spotentialmarket is>$300mInsidersinvested$26.5mI'm ashareholdermyselfOur Halo-Lido trial willhave finalpatient byend of 2022An actualiMSCupdateWe haveenough cashto go wellinto 2023We expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketI/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022Only biotechwith 2 Myron'son theleadershipteamMyron Holubiakand I founded aprivatecompany in2013We had aphase 2btrial with100%efficacyMino-WrapI won't diluteshareholdersMino-Lokis our leadassetWe will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"There are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityI/ONTAKis our leadassetI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokpotentialmarket>$1BNot manycompaniesthis size with2 late stageassets

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I/ONTAK's potential market is >$300m
  2. Insiders invested $26.5m
  3. I'm a shareholder myself
  4. Our Halo-Lido trial will have final patient by end of 2022
  5. An actual iMSC update
  6. We have enough cash to go well into 2023
  7. We expect to finish the Mino-Lok trial this year
  8. Hemorrhoids is a $2B market
  9. I/ONTAK was the best deal I ever made
  10. We intend to submit a BLA in 2H 2022
  11. Only biotech with 2 Myron's on the leadership team
  12. Myron Holubiak and I founded a private company in 2013
  13. We had a phase 2b trial with 100% efficacy
  14. Mino-Wrap
  15. I won't dilute shareholders
  16. Mino-Lok is our lead asset
  17. We will open up international sites for Mino-Lok trial
  18. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  19. There are no FDA approved drugs to treat hemorrhoids
  20. We will have exclusivity
  21. I/ONTAK is our lead asset
  22. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  23. Mino-Lok potential market >$1B
  24. Not many companies this size with 2 late stage assets